Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Insulin Detemir

Brand: Levemir ®
NICE TA: 
Indication: Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

Must be commenced by a healthcare professional who is appropriately trained and experienced in the initiation of insulin.
Insulin Detemir (Levemir®) is supported for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above. Recommendation: Green
Appropriate for initiation and ongoing prescribing in both primary and secondary care. Monitoring is required but this is routine monitoring required for all insulins.
The LMMG recommends Levemir FlexPen® as the 2nd line long-acting insulin analogue (1st line — Abasaglar KwikPen®).

Recommendation

LMMG recommendation: Green
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for initiation in primary care

Supporting documents:

New Medicine Recommendation - Insulin Detemir (191.5 KiB)

Algorithm For Antihyperglycaemic Therapy In Adults With Type II (Version 1.5) (454.0 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Green

Green

Green

Green

Green

Green